Blackstone Is Paying Up to $1.5 Billion for Pfizer’s Answer to Wegovy - 24/7 Wall St.
Blackstone Is Paying Up to $1.5 Billion for Pfizer’s Answer to Wegovy 24/7 Wall St.
Covered in this story
Analyst targets on Blackstone Inc.
- Citizens JMP: at $118 · target $165 by Oct 2027 · Market Outperform via Investing.com
- UBS: at $119 · target $122 by Sep 2027 · Neutral via Investing.com
- TD Cowen: at $130 · target $145 by Jul 2027 · Buy via Investing.com
“At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $BX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Blackstone Inc. →Summary aggregated from Google News's public RSS feed. The full reporting belongs to Google News — please read it on their site.